Study to Demonstrate Cognitive Enhancing Effects of BF2.649

NCT00690274 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: BF2.649
DRUG: Placebo

Sponsor

University of Texas Southwestern Medical Center

Collaborators

[object Object]
[object Object]